Bank of New York Mellon’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-513
| Closed | -$4.41K | – | 4296 |
|
|
2024
Q1 | $4.41K | Hold |
513
| – | – | ﹤0.01% | 4131 |
|
|
2023
Q4 | $1.8K | Hold |
513
| – | – | ﹤0.01% | 4299 |
|
|
2023
Q3 | $1.83K | Hold |
513
| – | – | ﹤0.01% | 4329 |
|
|
2023
Q2 | $2.99K | Sell |
513
-2,817
| -85% | -$16.4K | ﹤0.01% | 4363 |
|
|
2023
Q1 | $126K | Hold |
3,330
| – | – | ﹤0.01% | 4031 |
|
|
2022
Q4 | $99.2K | Sell |
3,330
-22
| -0.7% | -$656 | ﹤0.01% | 4118 |
|
|
2022
Q3 | $112K | Hold |
3,352
| – | – | ﹤0.01% | 4175 |
|
|
2022
Q2 | $134K | Sell |
3,352
-3,761
| -53% | -$150K | ﹤0.01% | 4168 |
|
|
2022
Q1 | $374K | Buy |
7,113
+2,859
| +67% | +$150K | ﹤0.01% | 3882 |
|
|
2021
Q4 | $235K | Hold |
4,254
| – | – | ﹤0.01% | 4205 |
|
|
2021
Q3 | $330K | Hold |
4,254
| – | – | ﹤0.01% | 4001 |
|
|
2021
Q2 | $553K | Hold |
4,254
| – | – | ﹤0.01% | 3720 |
|
|
2021
Q1 | $700K | Buy |
4,254
+1,133
| +36% | +$186K | ﹤0.01% | 3515 |
|
|
2020
Q4 | $730K | Buy |
+3,121
| New | +$730K | ﹤0.01% | 3433 |
|
|
2018
Q4 | – | Sell |
-132
| Closed | -$54K | – | 4293 |
|
|
2018
Q3 | $54K | Sell |
132
-6
| -4% | -$2.46K | ﹤0.01% | 4096 |
|
|
2018
Q2 | $75K | Sell |
138
-8
| -5% | -$4.35K | ﹤0.01% | 4031 |
|
|
2018
Q1 | $67K | Sell |
146
-35
| -19% | -$16.1K | ﹤0.01% | 4114 |
|
|
2017
Q4 | $121K | Buy |
181
+32
| +21% | +$21.4K | ﹤0.01% | 4033 |
|
|
2017
Q3 | $94K | Hold |
149
| – | – | ﹤0.01% | 4017 |
|
|
2017
Q2 | $72K | Buy |
+149
| New | +$72K | ﹤0.01% | 4082 |
|
|
2017
Q1 | – | Sell |
-65
| Closed | -$64K | – | 4330 |
|
|
2016
Q4 | $64K | Buy |
+65
| New | +$64K | ﹤0.01% | 4096 |
|